vranckx pascal
@pascal_vranckx
Followers
55
Following
10
Media
0
Statuses
42
Joined March 2021
Teaming up again with the great @VerwerftJan to share our experience with #echoCPET in #HFpEF. This hot-of-the-press paper @ESC_Journals demonstrates myriad of opportunities for diagnosis & treatment, far beyond #SGLT2i only. Tweetorial below! @SarahStroobant2 @HerbotsLieven
6
80
195
Really excited to present our latest paper @JACCJournals on how to organize a #dyspnoeaclinic for #HFpEF! Tweetorial below... https://t.co/WMDyfETR60 Implementation perspective = new item in #JACCHeartFail under @BiykemB leadership! Really the clinician's voice, just love it!
7
50
168
We just made it! #ECLS-SHOCK last patient in just happened!!! Congrats to the whole team! Another milestone in #cardiogenicshock treatment! @AGIKinterv @KardiologieHH @TRassafMD @YoungDgk @DGK_org @AnneFreund3 @hvanspall
31
49
256
Saddle PE WITH LARGE CLOT in transit! Completely removed! Big RA thrombus could probably have lead to PEA arrest RV:LV 2:1, elevated lactate/Troponin/BNP, PAP 80s on echo (normal recently)… (see echo below).
20
49
318
Really proud moment for me today, presenting 1st time in a Featured Science session @AHAScience. Deeper insight in #ADVOR trial with key contributions from @WilfriedMullens @PieterMartensMD @JeroenDauw @petra_nijst @EvelyneMeekers among many others. Proudly 🇧🇪! Tweetorial below!
14
71
257
Must be my hottest #AHA in the Windy City, beautiful skyline yesterday from Navy pier! Getting ready for my first LBT @AHAScience. Eager to learn results from TRANSFORM-HF! Some great science on #diuretics this meeting! Stay tuned for #ADVOR analyses tomorrow @PieterMartensMD
2
7
84
SPOT the DIAGNOSIS is 1 year #EHJACVC @ESC_Journals ! 🥳 We had some great submissions coming in, please continue to send us your materials and get in touch with our readership… @pascal_vranckx @EHJACVCEiC @krychtiukmd
1
5
39
Incredibly sad news. I completely share you view Gregg, interacting with him and learning from him was even better than having the manuscript finally accepted in the journal. RIP John and thank you for pushing me to dedicate MASTER DAPT to my parents at ESC presentation.
John Jarcho, Deputy Editor of Cardiology for NEJM, has died of pancreatic cancer. John was a truly kind person and an incredible physician. My many interactions with him over the years crafting NEJM articles made me a better writer and scientist. RIP John, you will be missed.
0
3
12
We got nearly 400 votes in, interesting result with a clear winner. However, I would argue that 83% of you have this wrong, explanation below…
If you have understood this well, who gets vasodilator therapy from you?
2
10
29
We should more frequently be brave and withdraw the manuscript when we encounter reviewers who simply want to show how good they are or even worse have intellectual biases…editors will start recognizing them and reviewers will stop destroying manuscripts just for the sake of..
We thank the reviewers for their suggestions and believe they have substantially improved the paper
2
7
49
In this issue of JACC interventions, three papers examine the outcomes of TEER in patients with Atrial FMR. Sonia Petronio, @hahn_rt, and myself wrote a combo editorial/mini review discussing the 3 papers & the nuances of studying aFMR in general https://t.co/dBqEDTecpS
0
38
132
Two‐year clinical outcomes after successful transcatheter aortic valve implantation with balloon‐expandable versus self‐expanding valves: A subanalysis of the GALILEO trial
onlinelibrary.wiley.com
Background Midterm data comparing clinical outcomes after successful implantation of self-expanding and balloon-expandable transcatheter heart valves (THV) are limited. We aimed to compare 2-year...
1
9
27
3 min to go for the great debate on mechanical circulatory support! #ESCCongress @seanvandiepen @susannaprice @CHassager @AGIKinterv @mmamas1973
1
10
35
Final 15 month results of MASTER DAPT on their way today at ESC…ready for additional information on how well or bad 1 month DAPT looks like in HBR patients at long-term? @masterdapt @mirvatalasnag @mmamas1973
1
23
76
Odyssey outcomes analysis presented today @Esc2022. Baseline lp(a) predicts revascularisation. Importantly, benefit of alirocumab in reducing revascularization appeared confined to patients with elevated lp(a), despite similar baseline and achieved LDL-c across quartiles 1/2
3
21
79
Vitamin K antagonists better than rivaroxaban in INVICTUS. The mechanism of (late) benefit (i.e., less death, sudden death or death due to mechanical or pump failure) is unclear: no difference in bleeding, not enough difference in stroke. #ESCCongress
https://t.co/ViE6ua7WyJ
8
67
170
0
2
16
Steffen Desch is making an excellent overview of #TOMAHAWK Very good algorithm how to manage these pts #OHCA #angio #CPR
#ESCCongress @susannaprice @rafavidalperez @CVandenbriele @mirvatalasnag @umityasarsinan1 @JohannesGrand @pascal_vranckx @saskavaska
1
4
11
Highlight of my career so far! From an idea conceptualised during my PhD, cultivated by 4 generations of PhD students after me under the watch of @WilfriedMullens, to a @NEJM publication and novel treatment for acute #HeartFailure
#acetazolamide #advor
https://t.co/Ib9hvdUStc
nejm.org
Whether acetazolamide, a carbonic anhydrase inhibitor that reduces proximal tubular sodium reabsorption, can improve the efficiency of loop diuretics, potentially leading to more and faster deconge...
60
197
958